Equities

Cell Impact AB (publ)

Cell Impact AB (publ)

Actions
  • Price (EUR)0.0153
  • Today's Change-0.001 / -8.38%
  • Shares traded18.00k
  • 1 Year change-29.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments10016529
Total Receivables, Net8.072531
Total Inventory644722
Prepaid expenses0.871.1647
Other current assets, total0.00--0.00
Total current assets173238128
Property, plant & equipment, net199154106
Goodwill, net------
Intangibles, net9.999.465.46
Long term investments0.02----
Note receivable - long term--0.020.01
Other long term assets0.000.00--
Total assets382402239
LIABILITIES
Accounts payable9.291315
Accrued expenses251555
Notes payable/short-term debt000
Current portion long-term debt/capital leases12113.44
Other current liabilities, total1.983.696.00
Total current liabilities484480
Total long term debt303316
Total debt434520
Deferred income tax------
Minority interest------
Other liabilities, total--0.00--
Total liabilities797796
SHAREHOLDERS EQUITY
Common stock688.786.81
Additional paid-in capital734693407
Retained earnings (accumulated deficit)(499)(377)(273)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0.001.95
Total equity303324143
Total liabilities & shareholders' equity382402239
Total common shares outstanding591239185
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.